Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh Aktie
| 10,67USD | 0,10USD | 0,95% |
WKN DE: A3DH5A / ISIN: US98390P1066
Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh | Quartalszahlen | 28.01.2025 |
| Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh | Quartalszahlen | 24.04.2025 |
| Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh | Quartalszahlen | 11.07.2025 |
| Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh | Quartalszahlen | 23.10.2025 |
| Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh | Quartalszahlen | 27.01.2026 |
| Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh | Quartalszahlen | 29.04.2026 |
| Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh | Quartalszahlen | 10.07.2026 |
| Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh | Quartalszahlen | 22.10.2026 |
| Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh | Quartalszahlen | 28.01.2027 |
Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 24.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 12.07.2024 |
| Hauptversammlung | Annual General Meeting | 25.04.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 24.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 25.01.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 24.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 13.07.2023 |
| Hauptversammlung | Annual General Meeting | 25.04.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 24.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 26.01.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 27.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 13.07.2022 |
| Hauptversammlung | Annual General Meeting | 26.04.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 25.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 27.01.2022 |
Nachrichten zu Xvivo Perfusion AB Unsponsored American Depositary Receipt Repr 1-4 Sh
| Keine Nachrichten verfügbar. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
